Deepinder Goyal's Temple claims discovery of biomarker that calculates cost of being alive; here’s what it means (opens original article in a new tab)
Deepinder Goyal's startup Temple introduced a biomarker called 'Entropy' to measure the real-time cost of being alive, but the company has not provided scientific validation or details on pricing and launch.
- Temple, founded by Deepinder Goyal, introduced a biomarker called 'Entropy' to measure real-time energy expenditure.
- Entropy is displayed as a live score from 1 to 250, with higher scores indicating intense physical exertion and lower scores showing rest states.
- The company has not disclosed scientific validation, pricing, or launch timelines for the biomarker.
Conversation
No comments yet
Threaded discussion is coming next — this is where the community conversation about this story will live.